🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Idiopathic Pulmonary Fibrosis (IPF)

Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis NCT05190211NA1 site📍 Istanbul Istanbul Medipol University Hospital · Tests: Telerehabilitation exercise program, Videobased exercise program Mechanisms of Familial Pulmonary Fibrosis NCT03437486n/a1 site📍 Nashville Vanderbilt University Medical Center D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis NCT06909409n/a1 site📍 Aarhus N University of Aarhus Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases NCT01600378n/a1 site📍 Singapore Singapore General Hospital The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis NCT06323876n/a1 site📍 Charlottesville University of Virginia · Tests: HRCT, Blood Draw Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis NCT04362644Phase 11 site📍 Birmingham University of Alabama at Birmingham · Tests: PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714 Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole NCT04965298Phase 357 sites📍 Norwich📍 Aberdeen📍 Antrim Norfolk and Norwich University Hospitals NHS Foundation Tru… · Tests: Lansoprazole, Matched placebo Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis NCT05674994Phase 329 sites📍 Angers📍 Besançon📍 Bobigny Fondation Hôpital Saint-Joseph · Tests: Methylprednisone/Prednisone, Placebo Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis NCT07299695Phase 31 site📍 Pátrai Argyrios Tzouvelekis · Tests: Intravenous immunoglobulin (IVIG), Usual treatment A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis NCT06968845Phase 248 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Rein Therapeutics · Tests: LTI-03, Dry Powder Inhaler, Placebo A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis NCT07516951Phase 219 sites📍 Dothan📍 St. Petersburg📍 Hannibal Chiesi Farmaceutici S.p.A. · Tests: CHF10067, CHF10067, Placebo An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) NCT06951217Phase 285 sites📍 Birmingham📍 Los Angeles📍 Newport Beach Avalyn Pharma Inc. · Tests: AP01 The Genetics of Pulmonary Fibrosis NCT03478553n/a1 site📍 Aurora University of Colorado, Denver · Tests: Blood draw, Questionnaire Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis NCT07447102Phase 21 site📍 Shanghai Dragonboat Biopharmaceutical Company Limited · Tests: BC006, Placebo Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease NCT07723872n/a1 site📍 Granollers Hospital de Granollers · Tests: Dual-site pulse oximetry (finger and earlobe) AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF NCT07194382Phase 249 sites📍 Camperdown📍 Kingswood📍 New Lambton Heights Avalyn Pharma Inc. · Tests: AP02, Placebo Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure NCT03500731Phase 1, Phase 22 sites📍 Pittsburgh📍 Pittsburgh Paul Szabolcs · Tests: CD3/CD19 negative hematopoietic stem cells, Rituximab, Alemtuzumab, Fludarabine, Thiotepa Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives NCT06036719n/a1 site📍 Paris Institut National de la Santé Et de la Recherche Médicale, … Study of ORJ-001 for the Treatment of IPF NCT07869147Phase 22 sites📍 Doral📍 DuBois Oorja Bio, Inc. · Tests: ORJ-001, Placebo Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis NCT05975983Phase 212 sites📍 Birmingham📍 Scottsdale📍 Los Angeles InSilico Medicine Hong Kong Limited · Tests: INS018_055, Placebo A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers. NCT06267183EARLY Phase 11 site📍 Shanghai Shanghai Synvida Biotechnology Co.,Ltd. · Tests: SV001, Placebo Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets NCT07671911Phase 322 sites📍 Newport Beach📍 Palm Springs📍 Redding Trevi Therapeutics · Tests: NAL ER, Placebo A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF) NCT07464912Phase 31 site📍 Beijing Beijing Tide Pharmaceutical Co., Ltd · Tests: TDI01 Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis NCT06567717Phase 21 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: Zinc, Placebos for zinc and nicotinamide riboside, Nicotinamide riboside Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland NCT06702228n/a1 site📍 Dublin Royal College of Surgeons, Ireland · Tests: Six minute walk test (6MWT), Computer-tomography of the thorax (CT Thorax), Quality of life questionnaires., Genetic Te… Identification of Diagnostic and Prognostic Biomarkers in the Pathological Continuum of Bronco Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis and Pulmonary Neoplasia NCT07707245NA1 site📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: Peripheral Blood Collection Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients NCT03535545Phase 11 site📍 Boston Massachusetts General Hospital · Tests: [68Ga]CBP8, PET Imaging A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. NCT07652658Phase 2198 sites📍 Birmingham📍 Phoenix📍 Phoenix AstraZeneca · Tests: Placebo for AZD8965, AZD8965 low dose, AZD8965 medium dose, AZD8965 high dose Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography NCT07174102n/a5 sites📍 Prague📍 Ferrara📍 Modena Azienda Unita Sanitaria Locale di Piacenza · Tests: High resolution computed tomography Daoyin Technique for Improving Exercise Endurance in IPF NCT07019714NA3 sites📍 Beijing📍 Zhengzhou📍 Shenyang Affiliated Hospital of Liaoning University of Traditional C… · Tests: Daoyin Technique, Routine Comprehensive Training
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy